Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MDMA-Assisted Therapy for Postpartum People With Co-occurring OUD and PTSD
NCT05219175Phase 2Recruiting
- Sponsor
- The University of New Mexico
- Start
- Apr 2024
- Primary completion
- Apr 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of midomafetamine in post-traumatic stress disorder (PTSD) and opioid use disorder (OUD), sponsored by The University of New Mexico. Primary endpoint: Clinician-Administered PTSD Scale for DSM-5 Total Severity Score. Started Apr 2024; status: recruiting.
02
Drugs
midomafetamine
03
Conditions
post-traumatic stress disorder (PTSD)opioid use disorder (OUD)
Beyond the preview
Go deeper on NCT05219175.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05219175.